Rating History for Seelos Therapeutics (SEEL) by Cantor Fitzgerald

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/21/2023 Charles C. Duncan Downgrade Neutral
(Overweight)
N/A
(N/A)
1.00
(1.28)
28% Details